Boston Scientific to market new balloon catheters

By Elaine Rigoli

Tampa, Fla., June 6 - Boston Scientific Corp. has received Food and Drug Administration clearance to launch its Sterling Monorail and Over-the-Wire Balloon Dilatation Catheter in the United States.

Both balloon catheter platforms are engineered for use in the renal and lower extremity arteries as well as in dialysis fistula, according to a news release.

In addition, the Sterling Monorail catheter received a specific indication for use in the carotid arteries as both a pre- and post-dilatation balloon.

"We have incorporated design elements from our industry-leading coronary balloon platform, the Maverick2 balloon catheter," said John Pedersen, president of Boston Scientific's peripheral interventions business, in the news release.

Based in Natick, Mass., Boston Scientific develops medical devices whose products are used in a broad range of interventional medical specialties.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.